These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34204146)

  • 41. Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach.
    Sanabria-Cabrera J; Medina-Cáliz I; Stankevičiūtė S; Rodríguez-Nicolás A; Almarza-Torres M; Lucena MI; Andrade RJ
    Curr Pharm Des; 2019; 25(36):3855-3871. PubMed ID: 31696806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiepileptic Medication-induced Severe Cutaneous Adverse Reactions in Hospitalized Children: A Retrospective Study.
    Abtahi-Naeini B; Makhmali R; Amini N; Reza Maracy M; Nouri N; Momen T
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):139-148. PubMed ID: 38822509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Severe skin reactions due to new medications].
    Mockenhaupt M; Paulmann M
    Hautarzt; 2018 Apr; 69(4):278-289. PubMed ID: 29568997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients.
    Jin HJ; Kang DY; Nam YH; Ye YM; Koh YI; Hur GY; Kim SH; Yang MS; Kim S; Jeong YY; Kim MH; Choi JH; Kang HR; Jo EJ; Park HK;
    Allergy Asthma Immunol Res; 2021 Mar; 13(2):245-255. PubMed ID: 33474859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea.
    Kang MG; Sohn KH; Kang DY; Park HK; Yang MS; Lee JY; Kang HR
    Yonsei Med J; 2019 Feb; 60(2):208-215. PubMed ID: 30666843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cutaneous Adverse Drug Reaction Caused by Antiepileptic Drug].
    Deguchi T; Abe R
    Brain Nerve; 2019 Apr; 71(4):401-406. PubMed ID: 30988229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatments for Severe Cutaneous Adverse Reactions.
    Cho YT; Chu CY
    J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe cutaneous adverse reaction associated with antiseizure medications: Diagnosis, management, and prevention.
    Brandt C; McGuire L; Uetrecht J
    Epilepsy Behav; 2021 Apr; 117():107844. PubMed ID: 33639435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.
    Godfrey H; Jedlowski P; Thiede R
    J Cutan Med Surg; 2024; 28(1):51-58. PubMed ID: 38189282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
    Kim HK; Kim DY; Bae EK; Kim DW
    J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
    Hama N; Abe R; Gibson A; Phillips EJ
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Lee ES; Kiuchi Y; Inomata N; Sueki H
    J Dermatol; 2023 Mar; 50(3):387-392. PubMed ID: 36121111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of cytotoxic proteins correlates with liver function impairment in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
    Yang F; Chen SA; Wu X; Zhu Q; Luo X
    Eur J Dermatol; 2018 Feb; 28(1):13-25. PubMed ID: 29521632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia.
    Loo CH; Tan WC; Khor YH; Chan LC
    Med J Malaysia; 2018 Apr; 73(2):73-77. PubMed ID: 29703869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea.
    Yang MS; Kim JY; Kang MG; Lee SY; Jung JW; Cho SH; Min KU; Kang HR
    Korean J Intern Med; 2019 Jan; 34(1):195-201. PubMed ID: 29466850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-κB activation.
    Osabe M; Tajika T; Tohkin M
    J Appl Toxicol; 2018 Feb; 38(2):274-283. PubMed ID: 28949055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
    Kang DY; Yun J; Lee SY; Koh YI; Sim DW; Kim S; Nam YH; Park JW; Kim SH; Ye YM; Park HK; Kim MH; Jee YK; Jung JW; Yang MS; Kim SH; Lee JK; Kim CW; Hur GY; Kim MY; Park SJ; Kwon YE; Choi JH; Kim JH; Kim SH; La HO; Kang MG; Park CS; Lee SM; Jeong YY; Kim HK; Jin HJ; Jeong JW; Lee J; Lee YW; Lee SE; Kim MS; Kang HR;
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):929-936.e7. PubMed ID: 32961314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.